Colgate-Palmolive (CL) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
UBS Remains Neutral Following Colgate-Palmolive's (CL) 4Q Earnings Report
February 1, 2016 8:43 AM ESTUBS maintained a Neutral rating on Colgate-Palmolive Company (NYSE: CL), and cut the price target to $67.00 (from $69.00), following the company's 4Q earnings report. CL delivered adjusted Q4 EPS of $0.73, $0.01 ahead of consensus. On the positive, CL's 2016 outlook implies a stronger underlying year ahead as... More
